Friday, July 3, 2015

Adaptimmune Therapeutics announces FDA acceptance of investigational new drug (IND) application for MAGE-A10 T in patients with non-small cell lung cancer

… advanced or metastatic non-small cell lung cancer (NSCLC).Says site initiation activities …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)